MabLyte's Seed VC Round

MabLyte raised a round of funding on April 11, 2013. Investors include Mercia Fund Management.

MabLyte is a life science, diagnostics company that will produce a range of kits for the analysis of the biological activity of monoclonal antibodies (widely used for the treatment of disease in man) …

Articles about MabLyte's Seed VC Round: